Hangzhou Tigermed Consulting Co., Ltd.

SZSE:300347.SZ

57.41 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009
Revenue 7,356.1737,085.4715,213.5383,192.2792,803.3092,300.661,687.0331,174.538956.998624.562336.519254.315193.264122.84462.793
Cost of Revenue 4,661.5984,277.0082,942.8831,678.0361,500.4061,308.913962.605727.874534.747328.998184.824130.166101.10263.76338.666
Gross Profit 2,694.5752,808.4642,270.6551,514.2431,302.904991.746724.428446.664422.251295.563151.694124.14992.16259.08124.127
Gross Profit Ratio 0.3660.3960.4360.4740.4650.4310.4290.380.4410.4730.4510.4880.4770.4810.384
Reseach & Development Expenses 254.352234.619211.829156.648124.04988.02549.66741.86427.5399.5625.97722.128000
General & Administrative Expenses 259.931256.06244.025161.435190.79172.69100.46577.16566.60859.72219.73619.79811.9437.4877.6
Selling & Marketing Expenses 187.315149.89129.39996.58181.07254.45439.74935.80831.66519.2157.4597.6075.2884.6672.929
SG&A 754.411405.951373.424258.015271.862227.144140.215112.97398.27378.93727.19527.40517.23112.15410.529
Other Expenses 2.991357.12307.514220.068156.04111.67214.42314.4820.9432.2188.756.7441.8891.7730.618
Operating Expenses 1,005.771997.69892.767634.731551.952461.396322.122267.853202.575131.17159.74655.18736.55824.09317.315
Operating Income 1,688.8032,582.3991,919.0431,122.4061,084.647595.851416.826197.942213.653169.461102.05871.95355.06334.5268.21
Operating Income Ratio 0.230.3640.3680.3520.3870.2590.2470.1690.2230.2710.3030.2830.2850.2810.131
Total Other Income Expenses Net 694.5472.9791,765.5231,096.3014.51575.72228.94433.2490.537.26918.869.7341.3461.3061.391
Income Before Tax 2,383.352,585.3773,684.5662,218.7071,089.162606.072431.25212.06220.206171.662110.80878.69656.9536.2958.204
Income Before Tax Ratio 0.3240.3650.7070.6950.3890.2630.2560.1810.230.2750.3290.3090.2950.2950.131
Income Tax Expense 338.606313.652292.864189.707113.83999.27599.07755.2846.31535.26616.06110.878.8524.0580.6
Net Income 2,024.852,006.5522,874.1631,749.775841.635472.184301.014140.652156.278125.49694.05767.74947.79231.7097.801
Net Income Ratio 0.2750.2830.5510.5480.30.2050.1780.120.1630.2010.2790.2660.2470.2580.124
EPS 2.342.323.312.21.130.630.410.20.240.190.150.130.0990.0670.019
EPS Diluted 2.342.323.32.191.130.630.410.20.240.190.150.130.0990.0670.019
EBITDA 2,027.8262,422.5512,107.9661,267.1481,009.403731.042500.627276.432266.394196.69499.23174.77959.71537.3498.057
EBITDA Ratio 0.2760.3420.4040.3970.360.3180.2970.2350.2780.3150.2950.2940.3090.3040.128